BSECompany Update2d ago · 28 Oct 2026, 12:19 pm
This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor interaction through a teleconference call on Thursday, 5 November 2026 at 2:00 p.m. (IST), post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached herewith.
Hester Biosciences Ltd · 524669
✦ AI SummaryResults
Hester Biosciences Ltd has scheduled an investor interaction through a teleconference call on November 5, 2026, to discuss the financial results for the quarter and six months period ended September 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
970b0157-e758-4421-8f2e-b6d898e306a8.pdf
View document text
28 October 2026
To, To,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra - Kurla Complex,
Mumbai 400 001 Bandra (E), Mumbai 400 051
Scrip Code: 524669 Symbol: HESTERBIO
Dear Sir/ Madam:
Subject: Intimation of earnings conference call
This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor
interaction through a teleconference call on Thursday, 5 November 2026 at 2:00 p.m. (IST), post
the announcement of financial results for the quarter and six months period ended 30 September
2026. Details for joining the call are attached herewith.
You are requested to take the above on record.
Sincerely
For Hester Biosciences Limited
Vinod Mali
Company Secretary & Compliance Officer
Enclosure: As above
is pleased to invite you to the
Q2 & H1 FY27 Results Conference Call
Hester Biosciences Limited
Represented by
Mr. Rajiv Gandhi, CEO & Managing Director
Ms. Priya Gandhi, Executive Director
Mr. Ashish Desai, Chief Financial Officer
Thursday, November 5, 2026
at 14:00 hrs India Time
Diamond Pass registration link:
Copy this Link in your browser: Link
Call Co-ordinator:
Mr. Abdulkader Puranwala: Phone: +91 22 6807 7339, e-mail: abdulkader.puranwala@icicisecurities.com
Ms. Nisha Shetty: Phone: +91 22 6807 7339, e-mail: nisha.shetty@icicisecurities.com
For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: rushad.kapadia@icicisecurities.com
Ms. Seema Sehgal: Phone: +91 9871116926, e-mail: seema.sehgal@icicisecurities.com
Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: minali.ginwala@icicisecurities.com